The new research suggests that long Covid patients were also fighting an immune battle against some pathogens. The researchers found that the reactivation of viruses, including Epstein Barr virus and some herpes viruses, occurred in such people.

The Chinese company producing Azvudone claimed that 40% of COVID-19 patients administered the drug for more than a week during the third phase of the clinical trial showed improvements when it came to symptoms

The rare viral disease’s spread in different populations outside Africa has alarmed scientists and investigations are on to ascertain the reasosns

Immunologist Satyajit Rath and NewsClick’s Prabir Purkayastha discuss the scientific concepts pertaining to viral infections and the mechanisms of vaccines against them

The research was conducted before the emergence of the Omicron variant and has raised concern about how capable double immunity would be against Omicron

Dr. Satyajit Rath talks about key aspects of the new drug, Molnupiravir, and points out that a lot that needs attention to make sure the drug becomes accessible to the poorer nations

Three bat species had viruses that are more than 95% identical with the one that causes COVID-19, a study found. This further boosts the argument that the SARS-CoV-2 virus had a natural origin

Various studies have revealed that autoantibodies have been a key driver of severe illness and deaths amongst people critically infected with COVID-19. Findings also show that autoantibodies’ concentration in human bodies increases with age

The Lambda variant, which was first identified in Peru, was declared as a variant of interest by the World Health Organization in June. It has reportedly spread to at least 31 countries

Amid new variants of the SARS-CoV-2 emerging across the world, experts explain how to ascertain whether a virus strain can escape the protection provided by a vaccine

Luis De Jesus writes about how Cuba plans to take on 2021, looking closely at the new ambitious economic development strategy “the Ordering Task”

The global response to the COVID-19 pandemic in terms of developing a vaccine has been unprecedented. However, there is still a lot to be understood about the disease and the virus which causes